PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site

Press Releases

Submit your press release via PR.com for Free

Receive press releases from companies in this category: By Email RSS Feeds:

PR.com is a leader in paid and free press release distribution. To reach journalists, increase online visibility, and attract new customers, submit via our global online news and press release distribution service to top search engines, thousands of websites, social media, blogger networks, as well as via print, broadcast, radio, mobile channels, and more.

A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in medication use and improvements in quality of life. The publication also notes that further economic... - May 18, 2016 - electroCore
DelveInsight, the leading market research and consulting company has added a new report Acute Ischemic Stroke - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 17, 2016 - DelveInsight
DelveInsight has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its Portfolio. - May 14, 2016 - DelveInsight
DelveInsight, the leading market research and consulting company has added new report Lysosomal Storage Disorder - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 14, 2016 - DelveInsight
According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 to 2020. - May 12, 2016 - DelveInsight
DelveInsight, the leading market research and consulting company has added new report Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. - May 11, 2016 - DelveInsight
Careington International Corporation CEO Barbara Williams will be attending the British American Business Council (BABC) annual Transatlantic Business Conference in London on May 11 and 12, 2016. Attending with Williams will be Bruce Bernstein, Assistant Vice President of Global Sales Development with Careington’s UK affiliate Munroe Sutton, and Head of Munroe Sutton’s Business Development division, Robert Malvasi. - May 11, 2016 - Careington International Corporation
Nutraceutical Company Powers Softgel Products to Vitamin and Supplement Businesses - May 10, 2016 - Makers Nutrition, LLC
The Slim Down Challenge, hosted by Seattle Sutton’s Healthy Eating (SSHE) of Minnesota, was a 16-week challenge for participants to improve their health and lose weight through their nutrition. Over 300 Minnesotans entered the Challenge, with 81 of them completing the full 16-week period, losing a total of 3097 pounds, and achieving substantial improvements in their health metrics as a result. - May 05, 2016 - Seattle Sutton's Healthy Eating
The Morgan Leary Vaughan Fund honored Edmund F. La Gamma, MD, Chief, Newborn Medicine at Maria Fareri Children's Hospital, a Member of the Westchester Medical Center Health Network, with the inaugural Lily Pedro Award for Excellence. The event, The 1st Annual Morgan's FunDay, was held at the Mahopac... - May 05, 2016 - The Morgan Leary Vaughan Fund, Inc.
Designed membership plans help consumers pay for complementary alternative medicine visits. - May 04, 2016 - RucorStrategies, LLC / Camcare
New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare
Sentynl Therapeutics, Inc. (“Sentynl”) announced that its commercial organization relaunched Abstral® in the United States. Sentynl acquired the rights to market Abstral® from Galena Biopharma in November 2015. Abstral® is indicated for the management of breakthrough pain in... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it acquired the rights to market Abstral® in the U.S. from Galena Biopharma. Abstral® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched Sentynl Patient Services to enhance patient access to its products. Sentynl Patient Services provides support to patients who want assistance with investigating their benefits, affording their medications and locating pharmacies... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Darren Pincus joined Sentynl as its Vice President and head of Business Development. Mr. Pincus is a highly experienced business development professional with a strong track record of successfully completed transactions. Prior to Sentynl,... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched its commercial organization including a full-time, professional sales force of key account specialists. About Sentynl Therapeutics. Sentynl provides healthcare professionals with treatment solutions that enable them to meet... - April 30, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Michael Hercz joined Sentynl as its Senior Vice President, General Counsel and Chief Compliance Officer. Mr. Hercz brings more than 18 years of legal, compliance and risk management experience to Sentynl. Prior to Sentynl, Mr. Hercz served... - April 30, 2016 - Sentynl Therapeutics, Inc.
Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for individuals... - April 27, 2016 - Universal Arts Compounding Pharmacy
ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to leptin... - April 26, 2016 - ALPCO
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for more... - April 22, 2016 - ValueCentric
DelveInsight, the leading market research and consulting company has added new report Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. - April 16, 2016 - DelveInsight
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research program,... - April 14, 2016 - Cayman Chemical Company
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their... - April 13, 2016 - DelveInsight
Medical device firm Noninvasix, Inc., developers of a patient monitoring system that accurately and noninvasively measures the amount of brain oxygenation in preterm infants, announced today that life science strategy expert Brett Giroir, M.D. has been appointed to the company’s Scientific Advisory... - April 13, 2016 - Noninvasix
The UK’s National Institute of Health and Care Excellence (NICE) has published guidance that electroCore’s non-invasive vagus nerve stimulation treatment (gammaCore) for the prevention and acute treatment of migraine and cluster headache is safe and can now be used in the NHS. The guidance... - April 09, 2016 - electroCore
Botox and fillers that are a proven way to eliminate one's facial wrinkles and fine lines in minutes are now offered at a discount online. - April 07, 2016 - Friends Salon N Spa
For most digital health adopters, the technologies use heightens patient satisfaction and reduces hospital readmissions, according to 2016 market data from the Healthcare Intelligence Network (HIN). - April 07, 2016 - Healthcare Intelligence Network
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA - the first cytokine assay in the STELLUX® Chemiluminescence product line. - April 06, 2016 - ALPCO
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 30, 2016 - DelveInsight
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
AXOQCS™ is complete business solution developed for Microsoft Dynamics AX that provides quality and compliance functionality. Pharmaceutical and Medical Devices manufacturers need a solution that is flexible, responsive, and integrated. AXOQCS™ is a unique ERP solution for Pharma and Life Sciences manufacturers that streamlines and integrates quality and compliance processes, helping them comply with FDA Good Manufacturing Practices while maintaining efficiency and profitability across business. - March 26, 2016 - AxSource
Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix
New Nutrition Bar Shuns Added Sugars, Sweeteners, GMOs; Says Good-Bye to Gluten - March 24, 2016 - Golda Bar
Are you plagued by stomach and intestinal issues, acid reflux, diarrhea, constipation, brain fog? Have you been to several doctors and haven’t seen any long term relief? This was author John Herron a few years ago. Herron decided to research the medical studies himself. What he found was stunning, there are solutions out there, but because they’re natural doctors don’t prescribe them. Now all of this is in the book, “The Gut Health Protocol.” - March 24, 2016 - The Gut Health Protocol
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
Local testosterone medical practice to open 11 additional diagnostic lab locations. - March 20, 2016 - Low T St. Louis
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 19, 2016 - DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 18, 2016 - DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 17, 2016 - DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - March 16, 2016 - DelveInsight
Source-Omega announces many new 3rd party DHA omega-3 supplement private labels approved to launch in the first half of 2016. Several of the new DHA products seek to benefit prenatal, pregnant and nursing markets in the USA, China and Singapore. SOURCE OIL® is a water extracted DHA algae oil from... - March 14, 2016 - Source-Omega
Tabula Rasa HealthCare CIO Joseph J. Filippoli was honored by SmartCEO Magazine with the 2016 Executive Management Award at a gala celebration March 8. The award recognizes the "leadership and accomplishments of Philadelphia's management all-stars. Winners are recognized for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic." - March 11, 2016 - Tabula Rasa HealthCare
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
Press Releases 601 - 650 of 2,834 Page: Previous | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next
Promote Your Business